Lindbrook Capital’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$17.4K Buy
1,342
+12
+0.9% +$159 ﹤0.01% 1418
2024
Q4
$17K Buy
1,330
+572
+75% +$6.92K ﹤0.01% 1373
2024
Q3
$8.44K Sell
758
-280
-27% -$3.09K ﹤0.01% 1766
2024
Q2
$11.7K Buy
1,038
+277
+36% +$3.22K ﹤0.01% 1541
2024
Q1
$9.44K Hold
761
﹤0.01% 1606
2023
Q4
$10.6K Sell
761
-36
-5% -$500 ﹤0.01% 1520
2023
Q3
$11.8K Buy
797
+36
+5% +$506 ﹤0.01% 1328
2023
Q2
$9.83K Buy
761
+34
+5% +$387 ﹤0.01% 1480
2023
Q1
$7.13K Sell
727
-38
-5% -$406 ﹤0.01% 1673
2022
Q4
$8.14K Sell
765
-47
-6% -$546 ﹤0.01% 1538
2022
Q3
$8K Buy
812
+85
+12% +$1.11K ﹤0.01% 1411
2022
Q2
$9K Hold
727
﹤0.01% 1285
2022
Q1
$8K Hold
727
﹤0.01% 1369
2021
Q4
$10K Hold
727
﹤0.01% 1260
2021
Q3
$14K Hold
727
﹤0.01% 864
2021
Q2
$7K Hold
727
﹤0.01% 1179
2021
Q1
$7K Hold
727
﹤0.01% 1141
2020
Q4
$3K Hold
727
﹤0.01% 1327
2020
Q3
$3K Hold
727
﹤0.01% 1254
2020
Q2
$6K Buy
727
+518
+248% +$2.62K ﹤0.01% 1004
2020
Q1
$1K Buy
+209
New +$969 ﹤0.01% 1433

Other funds holding DVAX

Lindbrook Capital's DVAX Position: Q1 2025 in Review

Lindbrook Capital increased its Dynavax Technologies (DVAX) stake by 0.9% in Q1 2025, buying an estimated $159 and bringing the position to 1,342 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1418.

Lindbrook Capital first reported a position in DVAX in Q1 2020 and has held it in 21 quarters since. 284 funds tracked by Wall St. Rank hold DVAX as of Q1 2025.

  • Lindbrook Capital held 1,342 shares of Dynavax Technologies worth $17.4K as of Q1 2025.
  • Lindbrook Capital bought 12 Dynavax Technologies shares in Q1 2025, an estimated $159.
  • Dynavax Technologies made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1418 holding.
  • Lindbrook Capital first reported a position in Dynavax Technologies in Q1 2020 and has held it in 21 quarters since.
  • 284 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.